Introduction
The coronavirus disease pandemic, the illness caused by severe acute
respiratory distress syndrome coronavirus 2 (SARS-CoV-2) was first
announced in an adult in China on 17 November 2019, and The World Health
Organisation (WHO) inform the epidemic of SARS-CoV-2 as a Emergency of
International Concern on January 30, 2020 (1,2).
There are rare data, particularly on infants and neonates with
congenital heart disease (CHD) and children with CHD are considered to
have a high risk to get COVID-19. Babies with CHD continue to be born at
the rate of 1 in 100 live births during the pandemic, and approximately
25% of these are considered critical CHDs requiring surgery or other
interventions in the first year of life. (3). History of cardiac surgery
may be associated with the risk of hospitalization in the intensive care
unit (ICU), intubation and mechanical ventilation, which is a more
severe form of the disease in newborns and children (4).
In this report, we present the management of SARS-CoV-2 infection in the
newborn after successful repair of aortic arch and ventricular septal
defect (VSD) closure surgery. Although extracorporeal membrane
oxygenation (ECMO) support was applied twice due to respiratory failure,
the patient died due to multiorgan failure. To our knowledge, this
patient was the first newborn to receive ECMO support for SARS-CoV-2
infection after congenital heart surgery. The consent was obtained from
the family for the publication of this study.